Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108.8 INR | +0.65% | +2.45% | -12.61% |
Business Summary
Number of employees: 296
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Formulations
91.9
%
| 1,754 | 90.4 % | 855 | 91.9 % | -51.25% |
Bulk Drugs
3.0
%
| 82 | 4.2 % | 28 | 3.0 % | -65.50% |
Processing Charges
2.4
%
| 79 | 4.1 % | 23 | 2.4 % | -71.36% |
Commission
1.1
%
| 17 | 0.9 % | 10 | 1.1 % | -40.22% |
Royalty
0.7
%
| 4 | 0.2 % | 6 | 0.7 % | +70.39% |
Export Incentives
0.5
%
| 5 | 0.3 % | 4 | 0.5 % | -13.61% |
Other Operating Income
0.4
%
| 0 | 0.0 % | 4 | 0.4 % | +4,940.00% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of World
52.8
%
| 535 | 29.2 % | 466 | 52.8 % | -12.95% |
India
47.2
%
| 1,300 | 70.8 % | 417 | 47.2 % | -67.91% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 01/10/01 | |
Director of Finance/CFO | 63 | 01/14/01 | |
Kishore P. Shah
CMP | Compliance Officer | - | 09/22/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 08/22/08 | |
Chairman | 73 | 08/23/08 | |
Director of Finance/CFO | 63 | 01/14/01 | |
Chief Executive Officer | 37 | 01/10/01 | |
Dhara P. Shah
BRD | Director/Board Member | 36 | 04/21/04 |
Shashil Mendonsa
BRD | Director/Board Member | - | 08/22/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 35,690,000 | 14,386,677 ( 40.31 %) | 0 | 40.31 % |
Company contact information
Lyka Labs Ltd.
Ground Floor, Spencer Building 30, Forjett Street
400036, Mumbai
+91 22 6611 2200
http://www.lykalabs.comGroup companies
Name | Category and Sector |
---|---|
Lyka BDR International Ltd.
Lyka BDR International Ltd. Pharmaceuticals: MajorHealth Technology Lyka BDR International Ltd. manufactures and markets finished pharmaceutical formulations and ready-to-fill lyophilized sterile active pharmaceutical ingredients products. It markets formulations in various dosage forms. The firm also sells human and veterinary products in Sudan. The company was founded on July 19, 1993 and is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- LYKALABS Stock
- LYKALABS Stock
- Company Lyka Labs Limited